Jing Lou

Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China.

Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The private company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu.

Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China.

Part of 3SBio, Inc., Ample Harvest Investments Ltd. provides investment services.

Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong.

Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China.

Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom.

Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The private company is based in Dongguan, China.